Keywords: biogen, pd, drug, passes, ph, ii, testing

Biogen's PD drug passes Ph II testing

Article | 27 March 2009

Print This

US drugmaker Biogen Idec says that interim results from Phase IIa studies of BIIB014, a drug candidate for Parkinson's developed ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in